These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 35856226

  • 1. [Sacubitril/valsartan attenuates left ventricular remodeling and improve cardiac function by upregulating apelin/APJ pathway in rats with heart failure].
    Liu HZ, Gao CY, Yuan F, Xu Y, Tian H, Wang SQ, Zhang PF, Shi YN, Wei JJ.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Jul 24; 50(7):690-697. PubMed ID: 35856226
    [Abstract] [Full Text] [Related]

  • 2. The effect of Sacubitril/Valsartan on cardiac function and cardiac remodeling in patients with heart failure with reduced ejection fraction.
    Chen F, Tian G, Bai X, Li J, Yuan Z.
    Ann Palliat Med; 2021 Aug 24; 10(8):8684-8691. PubMed ID: 34488357
    [Abstract] [Full Text] [Related]

  • 3. [Effect of sacubitril/valsartan on cardiac function in heart failure rabbits with preserved ejection fraction].
    Gao SY, Yao DH, Li JF, Xie QM, Jiang SC.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov 24; 47(11):887-893. PubMed ID: 31744278
    [Abstract] [Full Text] [Related]

  • 4. Effect of sacubitril valsartan on cardiac function and endothelial function in patients with chronic heart failure with reduced ejection fraction.
    Li BH, Fang KF, Lin PH, Zhang YH, Huang YX, Jie H.
    Clin Hemorheol Microcirc; 2021 Nov 24; 77(4):425-433. PubMed ID: 33386797
    [Abstract] [Full Text] [Related]

  • 5. [Protective effects of berberine against exhaustion exercise induced myocardial injury in rats].
    Wang YW, Li XD, Sun MJ, Liu ZP, Liu SW.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Aug 24; 47(8):647-652. PubMed ID: 31434437
    [Abstract] [Full Text] [Related]

  • 6. Study on the application effect of bisoprolol combined with sacubitril valsartan sodium tablets in the cardiac rehabilitation of patients with acute myocardial infarction combined with left heart failure after percutaneous coronary intervention (PCI).
    Chen C, Wu X, Li Y, Peng Y.
    Ann Palliat Med; 2021 May 24; 10(5):5455-5461. PubMed ID: 34044572
    [Abstract] [Full Text] [Related]

  • 7. The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction.
    Martens P, Beliën H, Dupont M, Vandervoort P, Mullens W.
    Cardiovasc Ther; 2018 Aug 24; 36(4):e12435. PubMed ID: 29771478
    [Abstract] [Full Text] [Related]

  • 8. Improved heart function and cardiac remodelling following sacubitril/valsartan in acute coronary syndrome with HF.
    Liu H, Su Y, Shen J, Jiao Y, Li Y, Liu B, Hou X, Jin Q, Chen Y, Sun Z, Xi Q, Feng B, Fu Z.
    ESC Heart Fail; 2024 Apr 24; 11(2):937-949. PubMed ID: 38224955
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The Difference between Sacubitril Valsartan and Valsartan on Vascular Endothelial Function, APN, MMP-9, and BNP Levels in Patients with Hypertension and Chronic Heart Failure.
    Du H, Li X, Zhao W, Jiang N.
    J Healthc Eng; 2022 Apr 24; 2022():9494981. PubMed ID: 35222898
    [Abstract] [Full Text] [Related]

  • 18. Assessment of sacubitril/valsartan effects on left ventricular dynamics using 3D echocardiography and 3D strain in heart failure with reduced ejection fraction patients.
    Öz TK, Abdelnabi M, Fiore C, Almaghraby A, Cihan D, Babazade N, Haseeb Raza Naqvi S, Omar B, Dağdeviren B.
    Minerva Cardiol Angiol; 2022 Aug 24; 70(4):431-438. PubMed ID: 34713680
    [Abstract] [Full Text] [Related]

  • 19. Canagliflozin Ameliorates Ventricular Remodeling through Apelin/Angiotensin-Converting Enzyme 2 Signaling in Heart Failure with Preserved Ejection Fraction Rats.
    Zhang T, Wang X, Wang Z, Zhai J, He L, Wang Y, Zuo Q, Ma S, Zhang G, Guo Y.
    Pharmacology; 2023 Aug 24; 108(5):478-491. PubMed ID: 37611563
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.